BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1933191)

  • 1. c-myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours.
    Rew DA; Taylor I; Cox H; Watson JV; Wilson GD
    Br J Surg; 1991 Sep; 78(9):1080-3. PubMed ID: 1933191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patients.
    Sundaresan V; Reeve JG; Wilson B; Bleehen NM; Watson JV
    Anticancer Res; 1991; 11(6):2111-6. PubMed ID: 1776848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear c-myc protein, maturation, and cell-cycle status of human haemopoietic cells.
    Bains MA; Hoy TG; Baines P; Jacobs A
    Br J Haematol; 1987 Nov; 67(3):293-300. PubMed ID: 3318911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
    Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
    Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of c-myc oncoprotein in mucinous and serous adenocarcinomas of the ovary.
    Sasano H; Nagura H; Silverberg SG
    Hum Pathol; 1992 May; 23(5):491-5. PubMed ID: 1314775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric quantitation of the c-myc oncoprotein in archival neoplastic biopsies of the colon.
    Watson JV; Stewart J; Cox H; Sikora K; Evan GI
    Mol Cell Probes; 1987 Jun; 1(2):151-7. PubMed ID: 3331172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the c-myc oncogene product in testicular cancer.
    Sikora K; Evan G; Stewart J; Watson JV
    Br J Cancer; 1985 Aug; 52(2):171-6. PubMed ID: 4027160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.
    O'Leary JJ; Landers RJ; Crowley M; Healy I; Kealy WF; Hogan J; Doyle CT
    J Clin Pathol; 1997 Nov; 50(11):896-903. PubMed ID: 9462237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of P62c-myc protein in breast cancer and its clinical significance].
    Yang J; Zhou L; Hu R; Zhao J; Yao X; Long Q; Fan W; Chen L; Xing T
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Dec; 29(4):399-401. PubMed ID: 10743237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
    Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
    Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
    Jones DJ; Ghosh AK; Moore M; Schofield PF
    Br J Cancer; 1987 Dec; 56(6):779-83. PubMed ID: 3325094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
    Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
    Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy.
    Polacarz SV; Hey NA; Stephenson TJ; Hill AS
    J Clin Pathol; 1989 Feb; 42(2):148-52. PubMed ID: 2921356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NO38 expression and nucleolar counts are correlated with cellular DNA content but not with proliferation parameters in colorectal carcinomas.
    De Angelis PM; Stokke T; Clausen OP
    Mol Pathol; 1997 Aug; 50(4):201-8. PubMed ID: 9350304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of DNA aneuploidy and c-myc oncoprotein content of canine plasma cell tumors using flow cytometry.
    Frazier KS; Hines ME; Hurvitz AI; Robinson PG; Herron AJ
    Vet Pathol; 1993 Nov; 30(6):505-11. PubMed ID: 8116143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.
    Curling M; Stenning S; Hudson CN; Watson JV
    J Clin Pathol; 1998 Jun; 51(6):455-61. PubMed ID: 9771445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-myc oncogene expression in anal squamous neoplasia.
    Ogunbiyi OA; Scholefield JH; Rogers K; Sharp F; Smith JH; Polacarz SV
    J Clin Pathol; 1993 Jan; 46(1):23-7. PubMed ID: 7679417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders.
    Ciclitira PJ; Macartney JC; Evan G
    J Pathol; 1987 Apr; 151(4):293-6. PubMed ID: 3295155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins.
    Evan GI; Hancock DC
    Cell; 1985 Nov; 43(1):253-61. PubMed ID: 3907852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer.
    Watson JV; Curling OM; Munn CF; Hudson CN
    Gynecol Oncol; 1987 Oct; 28(2):137-50. PubMed ID: 3311922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.